Peer Education for Gender Inclusion and Substance Use in Southern Africa

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-24
SponsorUniversity Hospital, Basel, Switzerland

About this trial

The goal of this trial is to test the effectiveness of a brief, behavioral peer group intervention called "PEGISUS" (Peer Education for Gender Inclusion and Substance Use in Southern Africa), on substance use, which will be embedded within existing vocational training programs in Zambia, Zimbabwe, and South Africa. Established peer groups who receive the PEGISUS intervention will complete nine sessions of an adapted intervention for substance use and gender equitable beliefs, embedded into vocational training programs. This will be compared to a standard of care control condition, which involves the vocational training program that is offered through the partner organization and a healthcare referral for substance use. The vocational training program partners are Sozo Foundation (South Africa), BuildIt International (Zambia), and Masvingo Polytechnic (Zimbabwe). Participants in both conditions will complete assessments at baseline, 12-weeks follow-up, and 24-weeks follow-up, consisting of self-reported questionnaires.

Eligibility criteria

Qualifiers

Adolescents and young adults 16 - 24 years old

At least weekly self-reported alcohol/drug use in a peer group in the past month or at least monthly heavy episodic drinking with peers over the past three months

Comfortable communicating in the predominant local language or English

Lives in the target community and plans to remain in the area for the next 12 months

Disqualifiers

Untreated major mental illness that interferes with study participation, such as active suicidality, or unmanaged bipolar disorder or psychotic disorder

Currently receiving psychological treatment for substance use

Participation in another VT/skills development program or another trial that is judged by the site investigator as non-compatible with this study

Unable to provide informed consent or informed assent

Trial design

Treatments tested in this trial

  • PEGISUS

Treatment groups

264 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University Hospital, Basel, Switzerland

Lead sponsor

SolidarMed

Collaborator

University of Zambia

Collaborator

Medical Research Council, South Africa

Collaborator